Decanoylcarnitine Inhibits Triple-Negative Breast Cancer Progression via Mmp9 in an Intermittent Fasting Obesity Mouse
Purpose: Treatment of triple-negative breast cancer (TNBC) remains challenging. Intermittent fasting (IF) has emerged as a promising approach to improve metabolic health of various metabolic disorders. Clinical studies indicate IF is essential for TNBC progression. However, the molecular mechanisms...
Main Authors: | Yifan Tang BS, Shuai Chen MS, Saijun Wang MS, Ke Xu BS, Kun Zhang BS, Dongmei Wang PhD, Ninghan Feng MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-02-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338241233443 |
Similar Items
-
Luteolin Inhibits Lung Cancer Cell Migration by Negatively Regulating TWIST1 and MMP2 Through Upregulation of miR-106a-5p
by: Qiang Wang MS, et al.
Published: (2024-04-01) -
A Retrospective Study of Gemcitabine and Carboplatin With or Without Intravenous Vitamin C on Patients With Advanced Triple-Negative Breast Cancer
by: Junwen Ou PhD, et al.
Published: (2020-02-01) -
circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
by: Jinling Yu MMed, et al.
Published: (2020-09-01) -
Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease
by: Veerendra Kumar Madala Halagappa, et al.
Published: (2007-04-01) -
Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
by: Ruo-Xi Wang, et al.
Published: (2018-09-01)